JAK1 frameshifts were significantly enriched in MSI-H endometrial cancers (38%; 50/131) versus microsatellite stable (MSS) endometrial cancers (<1%; 3/657), (Fig 2A, P = 1.78 x 10−39, Fisher’s exact test). Here, JAK1 is linked to endometrial cancer.